↓ Skip to main content

Dove Medical Press

An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action

Overview of attention for article published in Neuropsychiatric Disease and Treatment, July 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
2 X users
facebook
1 Facebook page
wikipedia
5 Wikipedia pages
video
1 YouTube creator

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
55 Mendeley
Title
An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action
Published in
Neuropsychiatric Disease and Treatment, July 2019
DOI 10.2147/ndt.s200568
Pubmed ID
Authors

Philippe Nuss, Florian Ferreri, Michel Bourin

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 55 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 16%
Researcher 7 13%
Other 5 9%
Student > Ph. D. Student 4 7%
Student > Master 4 7%
Other 8 15%
Unknown 18 33%
Readers by discipline Count As %
Neuroscience 10 18%
Biochemistry, Genetics and Molecular Biology 5 9%
Chemistry 4 7%
Medicine and Dentistry 4 7%
Agricultural and Biological Sciences 2 4%
Other 8 15%
Unknown 22 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 June 2023.
All research outputs
#7,360,834
of 25,385,509 outputs
Outputs from Neuropsychiatric Disease and Treatment
#948
of 3,131 outputs
Outputs of similar age
#126,183
of 363,724 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#32
of 101 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,131 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,724 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.